Public Health and Infectious Disease in the Philippines

As of 2026-08-31 · Updated 2026-08-31 · Section: Society, Human Rights & Public Safety · 日本語版

0. Twelve lines to grasp first

1. The big picture — "a country where infectious disease never left, and NCDs became the headline"

The Philippines' disease burden is a textbook case of the "double burden": a low-income-country pattern of infectious disease (TB, dengue, leptospirosis, diarrheal disease) coexisting with a middle-income-country pattern of non-communicable disease (NCD) burden. On the nutrition side, undernutrition and overnutrition coexist within the same country — even the same household — and in recent years, some have begun calling it a "triple burden" once micronutrient deficiency is added (The Varsitarian, July 28, 2026).

1-1. Macro indicators (all with year and source)

注 How to read the MMR figure: the 84 cited above is a model-based estimate, not a confirmed figure calculated directly from the Philippines' own registration statistics. 注 The spike to 153 in 2021 is understood not as a "registration disruption" but as a genuine deterioration during the COVID period, yet a single year's spike should never be cited on its own as "the Philippines' MMR." It is safer to present the 2020→2021→2023 trend together as a set.

注 Out-of-pocket spending at 44.4% (2023) is the backbone of this entire topic. It has improved from 50.4% in 2018, but over 40% of current health expenditure is still borne directly by households. The pathway of avoiding care → delayed diagnosis → more severe illness runs consistently through TB, NCDs, and maternal and child health alike.

1-2. The institutional framework

The 2019 Universal Health Care Act (RA 11223) notionally made every citizen a PhilHealth (Philippine Health Insurance Corporation) member. 注 A point commonly misunderstood: PhilHealth means "universal enrollment," not "full coverage." Thinking of it in terms of Japan's universal health insurance system will lead you astray (as the 44.4% OOP figure above demonstrates). Even in 2026, debates continue over the "24-hour confinement requirement" for benefits (ABS-CBN, June 15, 2026) and over the roughly ₱60-billion "excess fund" that PhilHealth has been asked to return (Inquirer.net, May 8, 2026).

2. Leading causes of death and non-communicable diseases (NCDs)

2-1. The latest cause-of-death statistics (PSA)

From the Philippine Statistics Authority's (PSA) registered mortality statistics. The following are provisional figures for January–November 2025 (per BusinessMirror, May 27, 2026, and GMA Network, May 28, 2026).

Total registered deaths for full-year 2025 stand at 566,709 (provisional), said to represent an 11.8% decrease from 642,622 in 2024.

注 This is the biggest trap in the whole dataset: it is risky to read this "11.8% decrease" as an actual drop in deaths. PSA's cause-of-death statistics shift substantially between provisional and final figures. Because registration delays tend to depress the provisional count, the interpretation that "deaths fell by a tenth in 2025" is quite likely unwarranted. Always confirm whether a figure is an estimate, a provisional figure, or a final figure.

注 Old figures still in circulation: in Japanese-language sources, the "2020 cause-of-death statistics" (the year COVID-19 ranked near the top) are still sometimes cited. 2020 was an unusual year in which self-harm deaths rose 57%, and it should not be cited as representative of a normal-times structure.

2-2. NCD risk factors (2025 DOST-FNRI survey)

Among adults (ages 20–59), per DOST-FNRI's (Department of Science and Technology's Food and Nutrition Research Institute) 2025 Updating Survey:

For diabetes, in addition to the PSA cause-of-death figure above (34,611 deaths in Jan–Nov 2025, ranked 5th), a prevalence rate of 7.5% (ages 20–79, 2024, IDF Diabetes Atlas) is also available. 注 Whenever a Japanese-language source cites "the Philippines has X million people with diabetes," always confirm whether it is an IDF estimate or a domestic survey (actual measurement). The WHO Philippines Office featured "advancing UHC for children with type 1 diabetes" on November 11, 2025, so securing care for children with type-1 diabetes is also a challenge.

In August 2026, 14 additional treatment drugs for cancer, diabetes, TB, and hypertension were made VAT-exempt (Inquirer.net, August 6, 2026). The fact that NCD policy is being implemented through "drug pricing" as an economic-policy lever is not widely understood on the Japanese side.

3. Tuberculosis (TB)

3-1. Rank and indicator — "world's #X" depends entirely on which indicator

Per the WHO tuberculosis fact sheet (2024 data, based on the Global Tuberculosis Report 2025):

(Verified against the WHO original in the 2026-08-25 review; all figures in the table above were confirmed to match. Source: WHO Tuberculosis fact sheet, https://www.who.int/news-room/fact-sheets/detail/tuberculosis — "an estimated 10.7 million people fell ill with TB worldwide" / "1.23 million people died from tuberculosis (TB) in 2024 (including 150,000 among people with HIV)" / "India (25%), Indonesia (10%), Philippines (6.8%), China (6.5%), Pakistan (6.3%), Nigeria (4.8%), Democratic Republic of the Congo (3.9%), and Bangladesh (3.6%)")

注 A discrepancy with another article (found in the 2026-08-25 review): field "Healthcare and Health" §8-2 had recorded the global estimated incidence as approximately 10.5 million, but the WHO original states 10.7 million (2024). That article has now also been corrected following this review. The arithmetic behind "6.8% ≈ 705,000 people" checks out against a base of 10.7 million (705÷10,700 = 6.6%).

How to phrase the ranking: the 6.8% figure is the share of estimated new patients (an absolute count), and by this indicator the Philippines ranks 3rd, after India and Indonesia. 注Ranking by "incidence rate" (per 100,000 population) would produce a completely different order (a high-incidence country with a smaller population would rank higher). When writing "world's 3rd," always specify "by estimated patient count." Do not use unqualified superlatives like "world's worst" or "Asia's worst."

3-2. Incidence rate — "approximately 500" is wrong

注 If you see a figure of "incidence rate approximately 500," it is not the estimated incidence rate. WHO's actual time series for estimated incidence is shown below, and the value 500 never appears in any year (World Bank indicator SH.TBS.INCD, sourced from the WHO Global TB Report, re-obtained 2026-08-25).

This is confirmed by the arithmetic as well — 625 per 100,000 × 112.73 million (PSA 2024 census) = approximately 705,000, consistent with 6.6–6.8% of the roughly 10.7 million estimated global cases. A rate of 500 per 100,000 would imply about 560,000 cases, or approximately 5.3% of the world total, which is not consistent with the 6.8% figure.

The "approximately 500" figure appears to be a notification-based value, and the gap between the estimate and the notification figure — the diagnosis gap — is itself the central issue in the Philippines' TB response. 注Describing these two figures as "different cuts of the same indicator" erases the very problem at stake.

注 Unconfirmed: the claim that "the Philippines accounts for 7.5% of the world's diagnosis gap, ranking 3rd after Indonesia and India" could not be traced, in this review, to the relevant chapter of the WHO Global TB Report 2025 and remains unconfirmed. 注The same report's patient-share ranking is "India 25% > Indonesia 10%," and there is no explanation for why only the gap ranking would reverse this order. Do not cite it as settled fact.

注 Treatment differs by source (made explicit in the 2026-08-25 review): field "Healthcare and Health" §8-2 presents the same "diagnosis gap 7.5%, 3rd after Indonesia and India" figure as a confirmed value in its table. This article's re-verification on 2026-08-25 likewise could not reach the WHO original (the relevant chapter/table of the Global TB Report 2025, or the corresponding page on who.int), and maintains the "unconfirmed" treatment. 注Neither version has been deleted. Anyone citing this should do so only after confirming the chapter and table number in the WHO Global TB Report 2025 original.

3-3. Domestic status (2025–2026)

Per a joint announcement by the WHO Philippines Office and the DOH (Department of Health) on November 12, 2025, among other sources:

The policy framework is PhilSTEP2 (Philippine Strategic TB Elimination Plan Phase 2) 2025–2030. An effort is underway to certify Guimaras Island as the country's first "TB-free island."

• NCR alone recorded 101,807 TB cases (as of February 2026, DOH; per Philstar.com and GMA Network, March 22, 2026).
• In March 2026, DOH pledged continued free TB medicine supply and priority allocation in the 2027 budget (DZRH, March 23, 2026).
• 注 On August 5, 2026, a new complaint was filed against the DOH secretary (reported as Secretary Pujalte) over alleged procurement suspensions of TB medicines (Rappler, August 5, 2026). Procurement and corruption risk bear directly on the effectiveness of TB control — this cannot be addressed by budget increases alone.
• In July–August 2026, the Philippines and the US concluded a 5-year, ₱42-billion (approximately $600 million) HIV/TB cooperation agreement (PNA, July 31, 2026, "US pledges P11.8-B" → settled at a total of ₱42 billion in early August 2026, per GMA Network/Manila Bulletin, August 10-11, 2026). 注Reports have carried conflicting figures — "₱11.8 billion," "₱37 billion," "₱42 billion" — reflecting confusion between an initial-year disbursement and the 5-year total. When citing this, always specify whether it is the 5-year total or a first-year figure.

As a structural factor, The Manila Times (March 22, 2026) argued that "the disease is curable, but inequality keeps it alive." Overcrowded housing, malnutrition, and delays in seeking care all reproduce TB incidence — a point the Japanese side cannot afford to overlook when planning programs.

4. HIV

4-1. What lies behind "fastest-increasing in the Asia-Pacific"

In June 2025, DOH recommended to the President that a national public health emergency be declared. On June 11 that month, WHO and UNAIDS jointly endorsed this call, stating that the Philippines faced "the fastest-growing HIV epidemic in the Asia-Pacific region" (WHO Philippines Office, June 11, 2025).

注 Two separate superlatives must not be conflated. What circulates are two claims that differ in both indicator and regional scope:

Mixing these two into "fastest-growing in the Western Pacific" is an error. Whichever claim you cite, always attach all four elements — indicator, regional scope, issuing body, and date.

4-2. Trend in the numbers — 2026 may mark a turning point

The "39% drop in Q2" reported by PNA on August 25, 2026 (the date this article was compiled) is the most recent turning point in this topic. 注 However, it is unconfirmed from the reporting whether the comparison is quarter-on-quarter or year-on-year. If it is a 39% drop from Q1's 4,633, Q2 would be roughly 2,830 cases. Carrying the "HIV keeps rising" framing of 2025 forward unmodified into 2026 would be a mistake. At the same time, part of the decline could reflect fewer tests being conducted (i.e., fewer detections) — a possibility that cannot be excluded, which makes it equally risky to declare that "infections have fallen."

注 Be careful with the figure "+9% year-on-year." 2026 Q1's 4,633 cases ÷ 90 days = 51.5 cases/day. If 2025 Q1 was "57 cases/day," the same period would be about 5,130 cases — a −9.7% change. Compared against 2025 Q4 (4,277 cases), however, it works out to +8.3%. The "+9%" figure likely mistook a quarter-on-quarter comparison for a year-on-year one. 注Always specify the comparison period.

Age group: In June 2025, DOH stated that cases among those aged 15–25 had risen approximately 500% (ABS-CBN/GMA Network, June 3, 2025). 注 The standard age bracket in DOH/PNAC epidemiological reporting (HARP) is "15–24," and the increase covers the period 2010–2023. Writing the multiplier without the time period invites a reading of "5x in the past year alone." Always pair the age bracket with the reference period.

Future projection: the DOH secretary warned that "without intervention, cases could reach 400,000 by 2030" (Manila Bulletin, June 3, 2025). 注This is a conditional scenario projection — neither a confirmed future value nor a current one.

注 An old figure: "a cumulative total of 120,000" (Philstar.com, February 2024) still circulates, but the cumulative reported case count as of Q1 2026 stands at 168,079, making the older figure substantially understated. 注Note also that "cumulative reported cases (168,079)" and "estimated PLHIV (approx. 288,000)" are different things — the latter is an estimate. The gap of roughly 130,000 represents the undiagnosed. Do not add or interchange the two.

4-3. The debate over the emergency declaration and the 2026 response

• June 3–6, 2025: DOH made its recommendation → it went to the Cabinet for discussion (PNA, June 5, 2025). Senator Loren Legarda voiced support. Meanwhile Representative Janette Garin opposed it, saying "a declaration is unnecessary" (Inquirer.net, June 4, 2025).
• As of August 25, 2026, this review could not locate primary-source confirmation that the President actually issued the declaration — treat it as "unconfirmed." Any Japanese-language article stating flatly that "an emergency has been declared" should be treated with caution.
• In December 2025, DOH warned that the "local concentrated HIV epidemic" continues (Inquirer.net, December 9, 2025).
• The number of DOH-designated HIV treatment hubs/care facilities stands at 305 (Inquirer.net, August 5, 2025).
• In June 2026, the securing of 15,000 doses of injectable PrEP was announced (PNA, June 8-10, 2026). The rollout of a long-acting prevention drug is early by Asian standards, but the quantity remains limited relative to the annual scale of new infections.
• 注 In January 2026, it was reported that DOH was considering mandatory HIV testing for foreign tourists (The Manila Times, January 25, 2026). This could bear directly on travel practicalities, but whether it has been formalized into policy remains unconfirmed. Do not copy this into Japanese-side travel guidance.
• On July 21, 2026, the CHR (Commission on Human Rights) noted in a "Zero HIV Stigma Day" statement that stigma remains a barrier to testing and treatment (Inquirer.net).

注 Deep-seated religious and political resistance persists over issues such as requiring parental consent for a minor's independent HIV test, and over condoms and comprehensive sexuality education, meaning that "medically obvious measures" are not simply implemented as such. The Manila Times reported "Alarm up over minors with HIV" on July 23, 2026.

5. Dengue and flood-linked infectious disease

5-1. The sharp decline in H1 2026

Structural factors likely at play include (1) the temporary depletion of the susceptible/immune population following the 2024–2025 major outbreak (an epidemic cycle effect), (2) rainfall patterns, and (3) strengthened DOH vector-control measures since 2025 — likely some combination of all three. 注 However, there is currently no basis for declaring that "dengue has begun a structural decline."

注 When writing "as of [date]," always distinguish whether it refers to the data cutoff date or the announcement/reporting date (the 93,155-case figure has a cutoff date of August 1 and a reporting date of August 8). PIDSR's cutoff and publication dates typically run 1–2 weeks apart.

5-2. The most important caution when reading the statistics

The World Health Organization Western Pacific Regional Office's (WPRO) "Dengue Situation Update" (issue #752, August 20, 2026) states plainly in its accompanying table that the Philippines' surveillance system (PIDSR, the Philippine Integrated Disease Surveillance and Response) carries a reporting lag of 2–3 weeks, making it difficult to compare recent weekly and cumulative figures against past years.

注 Consequently, "as of [date], down X% year-on-year" flash figures are routinely revised upward later. When reporting this in Japanese, always add the caveat "preliminary figure, subject to retrospective revision."

Vaccines: in February 2026, medical societies called for accelerated approval of a dengue vaccine (Inquirer.net, February 26, 2026), and the following day a proposal calling for "zero dengue deaths by 2030" was also put forward (same source, February 27). 注 However, given the lingering memory of the Dengvaxia controversy (§6-2), social acceptance of a new dengue vaccine cannot be taken for granted.

5-3. The August 2026 regional resurgence and flood-linked infectious disease

While the national figure is falling, localized deterioration has emerged in August.

• Dengue up 124% in CALABARZON (Rappler, August 23, 2026)
• Lapu-Lapu City exceeded its outbreak threshold; Cebu recorded 2 deaths and put 5 LGUs under watch (Philstar.com, July 26 and August 8, 2026)
• Tacloban City declared a "Code Blue" (Daily Tribune, August 18, 2026)
• Following flooding from the Habagat (southwest monsoon), leptospirosis cases rose. San Lazaro Hospital saw 3 deaths over 12 days (GMA Network/Daily Tribune, August 22-23, 2026). PhilHealth expanded its benefit package for moderate and severe leptospirosis (July 2026). Evacuation centers also saw warnings about influenza-like illness (ILI) (DOH, August 10-11, 2026).

Leptospirosis is the clearest public health consequence of this pattern. Urban flooding, inadequate drainage/sewer infrastructure, and rat-borne contamination combine directly, recurring every rainy season. It is practical to treat it, alongside dengue, as an "infrastructure-driven infectious disease."

6. Measles, rubella, polio, and vaccination — the long shadow of the Dengvaxia controversy

6-1. 注 "66% coverage" and "80% coverage" are different indicators

This is where numbers in this field are most often confused in Japanese-language sources. The two figures refer to entirely different indicators, so they must always be distinguished.

The trend for MCV1 (routine vaccination) is as follows — it collapsed to 64% in 2021 during COVID and has recovered to 80% by 2024, but remains well short of the 95% considered necessary for herd immunity:

注 Stating "the Philippines' measles vaccination rate is 66%" on its own is inaccurate. Always specify whether the figure refers to campaign coverage or the routine vaccination rate.

6-2. Measles and rubella in 2026

(Sources: DOH/Rappler, April 8, 2026; PNA, April 8, 2026; Outbreak News Today, April 11, 2026)

Regional variation and response:

• Northern Mindanao saw measles up 11%, with 74% of patients unvaccinated (Rappler, January 9, 2026). Mindanao accounted for 42% of national cases (PNA, January 19, 2026).
• Measles vaccination coverage in Mindanao/BARMM reached 82% (PNA, February 25, 2026). With support from UNICEF and others, BARMM reached 90% (UNICEF, March 2, 2026).
• NCR's MR campaign achieved 87.1% of its target (PNA, July 21, 2026).
• Ilocos Region ran a campaign targeting 95%, covering 444,000 children (PNA, July 7 and 16, 2026). A further vaccination drive covering approximately 445,000 children also launched in August 2026 (reported August 4, 2026).
• In April 2026, WHO highlighted vaccination outreach to remote areas of Zamboanga del Norte (WHO Philippines Office, April 7, 2026).

Regional disparities are very large — reading only the "national 66%" average will misrepresent reality on the ground.

6-3. What the Dengvaxia controversy left behind

Dengvaxia (made by Sanofi), the world's first dengue vaccine, was administered on a large scale through a school-based program in 2016. It became politically explosive after the manufacturer announced in November 2017 that it could raise the risk of severe disease in people who had never previously been infected with dengue.

The London School of Hygiene & Tropical Medicine (LSHTM) surveyed 1,500 people in each of 2015 and 2018 using an identical design, finding:

(Source: LSHTM, October 12, 2018)

This stands as one of the most dramatic collapses of vaccine confidence in public health history, and is understood as a common root behind the subsequent measles outbreak (2019), the re-emergence of polio (2019), and the depressed vaccination rates persisting into 2026. As recently as August 2026, Rappler still found it necessary to run a fact-check article titled "MR vaccine is safe and effective" (August 14, 2026).

注 When the Japanese side discusses "why aren't vaccination rates rising," always factor in the 2017 collapse of trust, not just poverty and access. Conversely, the domestically circulated claim that "hundreds died from Dengvaxia" has not been settled either judicially or scientifically, and should not be treated as established fact.

6-4. Polio

• The Philippines declared an outbreak of circulating vaccine-derived poliovirus (cVDPV) in 2019, with the outbreak confirmed ended in 2021.
• In WHO's Polio IHR Emergency Committee statement (March 4, 2026, covering the period January 1–December 31, 2025), the Philippines does not appear on the list of countries with cVDPV infection. 注However, the statement's ordinal number ("44th," etc.) is unconfirmed — this review could not access the relevant page on who.int. Anyone needing to cite the ordinal should verify it against the original WHO statement's title.
• 注 Papua New Guinea (PNG) does appear on the same list as a cVDPV2-infected country. With a transmission source within the Western Pacific region and MCV1 hovering around 80%, the risk of reintroduction has not disappeared.

7. COVID-19: a summing-up

(Source: figures reported to WHO, via Our World in Data. The time series has shown no change since January 2024, and remains the same as of July 19, 2026.)

注 This should not be read as "COVID stopped occurring after 2024." It merely reflects that routine surveillance reporting has effectively ended, freezing the counter. Cases were reported rising in Quezon City in July 2026, which experts described as "within the normal range" (Inquirer.net, July 8, 2026).

COVID's true scars are inscribed not in the case count but in the macro indicators discussed in §1-1 above: life expectancy 70.10 (2020) → 66.68 (2021); MMR 88 (2020) → 153 (2021); MCV1 79% (2020) → 64% (2021). 注 The fact that all three collapsed in the same year is the essence of the Philippines' COVID period.

On the institutional side, PhilHealth scaled back COVID-related benefits in November 2024, sparking debate over how the fund's resources should be used (Inquirer.net, November 18, 2024). The pandemic's institutional legacy can be summarized in three points: ① testing and surveillance infrastructure; ② the politicization of PhilHealth's fund; and ③ health-worker burnout and attrition.

8. Maternal and child health, and teenage pregnancy

8-1. The historic decline in the birth rate

• Total fertility rate (TFR) of 1.7 (2025 National Demographic and Health Survey/NDHS, per PNA, March 30, 2026) — a historic low, below the replacement level.
• 注 The premise that "the Philippines is a high-fertility country" no longer holds as of 2026. GMA Network ran a piece on June 26, 2026 asking whether "record-low fertility is good news or bad news."

8-2. Teenage pregnancy — the total is falling, but the youngest bracket is rising

The adolescent fertility rate (women aged 15–19) has clearly declined (World Bank/UN estimates):

A roughly 36% decline over seven years is the clearest improvement in this entire field.

This is the most important paradox here: while the overall teen birth count is falling along with the birth rate, it is rising in the most vulnerable bracket — ages 10 to 14. The Council for the Welfare of Children (CWC) has noted that most of these cases involve adult men, and argues that before being a public health issue, this is fundamentally a child-protection and sexual-exploitation issue (PageOne.ph, March 24, 2026).

注 Citing only the headline "teen pregnancy has fallen" misses this structure entirely. Always break the figures down by age bracket.

On the legislative front, Senator Risa Hontiveros' "Prevention of Adolescent Pregnancy Act" (an alternative to Senate Bill 1979) has been debated, but 注at least seven senators have withdrawn support, stalling it (Asia Sentinel, February 7, 2025). Senator Hontiveros indicated intent to refile it in May 2025 (PNA, May 21, 2025), but as of August 2026, its passage cannot be confirmed — unconfirmed. Resistance from religious conservative groups over comprehensive sexuality education remains the biggest constraint in this field.

8-3. Maternal mortality

MMR stands at 84 per 100,000 live births (2023, WHO-UN MMEIG model estimate, via World Bank). 注 This is an estimate, not a confirmed figure derived directly from PSA's own registration statistics. Do not cite the 2021 spike to 153 in isolation as "the Philippines' MMR" (see §1-1).

• In May 2025, DOH warned of a surge in maternal deaths in Northern Mindanao (Rappler, May 22, 2025).
• In May 2026, PhilHealth expanded maternity benefits (PNA, May 20, 2026/ABS-CBN, June 4, 2026). UNFPA welcomed this (April 30, 2026). UNFPA and PhilHealth signed an agreement to advance RPRH and UHC (June 2, 2026).
• 注 Inquirer.net reported in 2023 that "the true MMR is worse than the published figure," pointing to underreporting as an issue. The gap between model-based estimates and registration statistics is an inherent feature of this indicator.

9. Nutrition — the double burden of stunting and obesity

DOST-FNRI's 2025 Updating Survey (Nutritional Status of Filipino Children and Other Population Groups). The survey period ran April 23, 2025–March 31, 2026, covering all 118 provinces/highly urbanized cities, reaching 91.5% of target households. Results were published at the June 2026 National Nutrition Summit.

9-1. Undernutrition

(Sources: DOST-FNRI 2025 Updating Survey; EDCOM 2, June 17, 2026/BusinessWorld, June 17, 2026)

The biggest news of 2026 is that stunting in children under 5 has turned upward for the first time in ten years. The National Nutrition Council (NNC) has warned of "a worsening nutrition situation" (Philstar.com, July 13, 2026). 注 2026's food-price increases (from higher fuel costs and a weaker peso, driven by the Middle East conflict, see §14) could worsen this further, but data demonstrating this causal link do not yet exist — unconfirmed.

9-2. Overnutrition

注 A point that must never be gotten wrong: this "44.5% obesity" figure is measured under the Asia-Pacific BMI standard (a classification with lower thresholds tailored for Asian populations). It is an entirely different measure from "obesity" under the WHO standard (BMI ≥30), and must not be compared directly with other countries. Writing simply "44.5% of Filipinos are obese" in Japanese risks serious misunderstanding.

Obesity is higher among the wealthy and urban populations, while stunting is higher among the poor, rural areas, and BARMM — a nutritional divide within the same country. This is the real picture behind the "double burden."

As a policy response, front-of-pack nutrition labelling is being promoted by the WHO Philippines Office (May 28, 2026). This is worth watching as a move toward tackling NCDs from the food-policy side.

10. Smoking and e-cigarette regulation

The regulatory framework and 2026 developments

• RA 11900 (the Vaporized Nicotine and Non-Nicotine Products Regulation Act, 2022) regulates e-cigarettes and heated tobacco products. 注 This law is said to have shifted the regulating authority from health agencies to the DTI (Department of Trade and Industry) and lowered the purchase age to 18, and continues to draw strong criticism from DOH, WHO, and health-focused organizations. The debate does not hold together if the context that "RA 11900 was a setback for public health" is dropped.
• 2026 has become the year full-ban arguments went mainstream:
• May 6, 2026: DOH proposed a full ban on e-cigarettes. Senator Hontiveros stated that "current safeguards are insufficient" (ABS-CBN).
• May 7, 2026: senators voiced support for DOH's call for a full ban (Manila Bulletin).
• July 10, 2026: DOH was reported to be pushing for a full ban (Daily Tribune).
• July 27, 2026: ahead of the SONA (State of the Nation Address), local government units (LGUs) asked the President to prioritize "anti-smoking/anti-vape" legislation (Inquirer.net).
• Smuggling and illicit products are the reality on the ground: on March 16, 2026, DTI stated that "the flavored vapes being sold domestically are smuggled goods" (PNA). On March 14, DTI and the BIR seized roughly ₱3.6 million worth of illegal vape products (Manila Bulletin).
• In May 2026, over 6,000 young people demanded an immediate vape ban through a nationwide campaign. That same month, MMDA-led enforcement of the ban on tobacco sales near schools was strengthened (journal.com.ph, May 25, 2026).

The pattern is clear: the central law (RA 11900) is lax, while DOH, the Senate, LGUs, and civil society each push, independently, to tighten it — a situation that continues to hold as of 2026. 注 As of August 2026, no full ban has been enacted — unconfirmed. Do not write that "the Philippines has banned vaping."

11. Mental health (RA 11036) and suicide

11-1. The legal framework

RA 11036 = the Mental Health Act (2018). It sets out national mental health policy, protects rights, integrates services at the community level, and folds coverage into insurance benefits — relatively early legislation by Southeast Asian standards.

注 However, "having a law" does not mean "having a service." Rappler concluded on February 26, 2025 that "the 2018 Mental Health Law: is it working? Awareness has improved, but doctors are lacking." Inquirer.net (September 5, 2024) reported that the Philippines has fewer than 1 mental health worker per 100,000 population.

11-2. The numbers

注 Suicide as recorded in registered mortality statistics tends to undercount the true figure, due to stigma and issues with how cause of death is recorded — a pattern common across countries, and the Philippines is no exception. Do not treat "2,734" as the actual figure. A common error is also to conflate the number of inquiries (7,189) with the number of deaths (2,734).

注 What deserves attention is that three figures pointing in different directions appear at once: PSA's provisional figure shows suicide deaths roughly flat at −3.1%, while "deaths related to mental and behavioral disorders" are up +55.5%, and NCR suicides are up more than double. Both a change in how causes of death are classified, and regional skew, are possible explanations, and a single figure should not be used to declare that "suicide in the Philippines has risen" or "has fallen."

11-3. 2025–2026 developments

• NCMH and the Unilab Foundation piloted a school-based referral system in Mandaluyong City (Philstar.com, September 2, 2025). Quezon City strengthened community mental health services (PNA, September 10, 2025).
• On October 28, 2025, ABS-CBN reported that the most common reason cited for seeking counseling is depression. A tendency for inquiries to cluster around year-end/New Year (452 cases December 21–26, 2025, rising to 612 by month's end) was also reported (Inquirer.net).
• In February 2026, Senator Robin Padilla apologized for calling young people "weak." A concrete example of stigma still being reproduced at the political level (ABS-CBN, February 12, 2026).
• On May 11, 2026, DepEd (Department of Education) launched a Telesafe Helpline for students (PNA). On May 21, a bill addressing anxiety and depression among college students was filed (Manila Bulletin).
• On June 2, 2026, Ateneo de Manila University and NCMH partnered on AI-assisted crisis intervention (Ateneo de Manila University). Using technology to fill resource gaps is an area with significant room for Japanese-side cooperation.
• In March 2026, DOH expressed concern for the mental health of Filipinos in Middle East crisis zones. BusinessMirror ran a piece on April 2, 2026 on "economic hardship and quiet suffering," reflecting a shared recognition that the 2026 economic shock is spilling over into mental health.

12. Water and sanitation (WASH)

12-1. National figures finally confirmed (original series obtained on 2026-08-25)

Using a series sourced from the WHO/UNICEF JMP (Joint Monitoring Programme) via the World Bank, the following has now been confirmed.

(Sources: World Bank indicators SH.H2O.SMDW.ZS / SH.STA.SMSS.ZS / SH.STA.ODFC.ZS, all sourced from WHO/UNICEF JMP. Re-obtained via API on 2026-08-25, extending the series through 2024. Last updated 2026-07-13)

注 (Corrected in the 2026-08-25 review) the earlier version treated 2023 as the latest year, but the JMP/World Bank series has already published figures through 2024. Field "Water and Sewerage" §0/§ already adopted the 2024 figures of 48.5%/62.2%, so it was a year out of step with this article. This table has now been extended to 2024 to bring the two into alignment. (The apparent difference is purely a rounding convention — 48.48% shown as "48.5%," 62.17% as "62.2%" — it is the same underlying series.)

The most important takeaway is that "safely managed drinking water sits at 48.5% (2024) — under half the population." 注 Figures such as "the Philippines' water-supply penetration exceeds 90%" circulate in Japanese-language sources, but that refers to "access to an improved water source" (basic), which is an entirely different thing from "safely managed" (on-premises, available when needed, and meeting water-quality standards). Always specify the indicator name.

Open defecation stands at 2.18% (2024) — against a population of 113 million, that is approximately 2.46 million people. It continues to improve, but the absolute number remains large. (Updated from 2.54%, or roughly 2.8 million people, in 2023, per the 2026-08-25 review)

注 On the figure "sewer connection rate approximately 10%": this is repeatedly cited in Japanese-language sources, but this research could not reach the original source either (the JMP's sewer-connection breakdown, or NEDA's water supply and sanitation master plan) — unconfirmed. 注Do not read the "safely managed sanitation, 62.2% (2024)" figure above as the sewer-connection rate. Sanitation facilities in the Philippines are overwhelmingly on-site systems such as septic tanks, and the vast majority of that 62.2% is not sewer-connected. Field "Water and Sewerage" §0 likewise states that "even in Metro Manila's East Zone, about 85% of households rely on septic tanks" (per Manila Water's own published figures), which reflects the reality on the ground. If you use this figure, confirm the original source first, citing it as "[X] year's figure from [Y] agency."

12-2. The operational reality (scale-related facts that have been confirmed)

Leptospirosis is the clearest public health consequence (see §5-3). Urban flooding combined with inadequate sewer/drainage infrastructure and rat-borne contamination combine directly, and recur every rainy season.

On July 20, 2026, the WHO Philippines Office featured efforts to scale local cholera-response lessons into national policy. 注However, no reporting of a nationwide cholera outbreak could be confirmed in 2026, so stating that "cholera is currently epidemic in the Philippines" would be inaccurate at this time.

13. Outflow of the health workforce and the state of care delivery

From EDCOM 2's (Second Congressional Commission on Education) workforce development plan, "A Decade of Necessary Reform 2026–2035" (February 2026).

注 The pipeline figures do not add up arithmetically. Do not simply cite them as-is. The reported figures — 33,000 annual entrants, an estimated 15,000 annual dropouts, and 26,000 annual graduates (of whom approximately 11,000 fail the licensure exam) — leave an 8,000-person gap between entrants-minus-dropouts (18,000) and graduates (26,000). The "56% who never reach the workforce" figure also does not reconcile: 33,000 × 56% = 18,480, which does not match dropouts (15,000) plus exam failures (11,000) = 26,000. The likely cause is that each figure's reference year and scope of covered programs are not aligned. 注Do not add or subtract these as if they were breakdowns of the same cohort. If citing this data, it is safer to stick to indicators that stand alone and are internally consistent, such as "total shortfall: approximately 290,000," "density: 21.2 per 10,000," or "annual outflow: approximately 27,000."

The core structural point holds regardless — "a training pipeline with major leakage along the way" and "those who do make it out then leaving the country" are compounding one another. The nursing shortage cannot be solved simply by expanding training-program capacity.

Related 2025–2026 developments: - The US eased its visa freeze for foreign doctors (Asian Journal News, May 4, 2026) → outward pressure has risen again. - Discussions continue over revising the Germany-Philippines migration framework (GIGA Hamburg, April 12, 2026). On August 4, 2026, the DMW (Department of Migrant Workers) began considering scholarships for Filipino nurses working in Germany (SunStar). - The "Doctors to the Barrios" return-to-service program sustains rural healthcare (PIA, May 27, 2026). A bill to encourage pharmacists and healthcare workers to stay in the country is also in progress (Manila Bulletin, February 25, 2026). - On March 31, 2026, health workers held a Holy Week protest in front of DOH headquarters, demanding wage increases and support "amid the impact of the Middle East crisis" (Rappler).

注 The persistent misconception that "the Philippines is a nurse-exporting country, so it must have plenty at home" is misleading. In reality, the domestic supply is chronically short-staffed, with extreme regional disparities.

14. The 2026 Middle East conflict (beginning February 28) and its spillover into public health

The Middle East conflict that began on February 28, 2026 has affected the Philippines' health sector both directly (OFWs on the ground) and indirectly (fuel, exchange rate, supply chains).

The public health implications:

1. Medicine is almost entirely import-dependent, so fuel costs and the exchange rate (a weaker peso) directly push up drug prices and hospital operating costs. The August 2026 measure making 14 additional drugs VAT-exempt (Inquirer.net, August 6) can be read as a response to this pressure.
2. The Middle East is one of the largest employers of Filipino nurses and caregivers, and repatriation could temporarily ease domestic workforce supply. However, with 84% of returnees hoping to go abroad again, the structural outflow remains unchanged.
3. A decline in remittances directly hits households' capacity to pay for healthcare. With out-of-pocket spending accounting for 44.4% of current health expenditure (2023), this shifts onto the disease burden in the form of delayed care-seeking.
4. The spillover into nutrition is the most concerning channel. The food-price shock has arrived just after stunting rose for the first time in a decade in 2025 (§9-1), and the 2026 survey could show further deterioration.

注 The above represents "confirmed reported facts." Data showing the quantitative impact on health indicators (changes in care-seeking rates, mortality, or nutrition indicators) had not been published as of August 2026 — unconfirmed. Do not assert causation as settled.

15. Practical notes — common mistakes the Japanese side makes in this field

The nature of this article: any "unconfirmed" note in the text above means that, as of 2026-08-25, the primary source could not be reached — it does not mean "this is wrong." When citing this material, always attach three things: the indicator name, the year, and the issuing body.

日本語の詳細版: 分野「社会・人権・治安」「フィリピンの公衆衛生と感染症」（本サイト日本語版）。